Recurrent Breast Cancer

Breast Cancer Patients Are Now Living Longer without Relapse (12-18-2014)

Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings were recently published in the Journal of Clinical Oncology. Cancer... Continue Reading

Neratinib Continues to Show Activity in HER2-Positive Breast Cancer (12-15-2014)

Interim results from an ongoing Phase II clinical trial of neratinib were presented at the 2014 San Antonio Breast Cancer Symposium (SABCS). Neratinib is an investigational, oral medication that targets HER2 as well as HER4 and the epidermal growth factor... Continue Reading

Initial Results of PD-1 Checkpoint Inhibitors Evaluated in Triple-Negative Breast Cancer Presented in San Antonio (12-10-2014)

The initial results from a phase 1 trial evaluating the checkpoint inhibitor Keytruda® (pembrolizumab) in patients with heavily pretreated triple-negative breast cancer were recently reported at the San Antonio Breast Cancer Symposium (SABCS). The cancer... Continue Reading

Second-line Avastin Improves Progression-Free Survival in Advanced HER2-Negative Breast Cancer (10-20-2014)

Adding Avastin® (bevacizumab) to chemotherapy in second-line treatment of advanced HER2-negative breast cancer improves progression-free survival. Results of the phase III TANIA trial evaluating the role of Avastin® in advanced breast cancer were recently... Continue Reading

Impressive Survival Gains with New First-Line Therapy for HER2-Positive Metastatic Breast Cancer (10-9-2014)

According to recent findings, the combination of targeted agents Herceptin® (trastuzumab) and Perjeta® (perjeta) significantly improves survival for patients with HER2-positive metastatic breast cancer when added to chemotherapy. This data was presented... Continue Reading

Walk or Run Your Way to a Reduced Risk of Breast Cancer (09-24-2014)

Want to reduce your risk of breast cancer? Lace up those shoes and get moving—because exercise has a significant impact. There is a growing body of evidence to indicate that exercise is crucial to reducing the risk of cancer. Now a new study has put... Continue Reading

Vaccine Derived from HER2 Protein May Help Prevent Breast Cancer Recurrence (09-16-2014)

A new breast cancer vaccine that is derived from the HER2 protein may help prevent recurrence in patients with HER2-positive disease and appears safe. Phase II study results of the vaccine were released at the 2014 Breast Cancer Symposium, September 4–6,... Continue Reading

New Guidelines on Treatment of HER2-Negative Breast Cancer Aim to Improve Patient Outcomes (09-9-2014)

The American Society of Clinical Oncology (ASCO) recently released updated guidelines for the treatment of advanced HER2-negative breast cancer. The Journal of Clinical Oncology will publish the new guidelines, which include hormone therapy and sequential... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (08-28-2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Ask the Expert: Making Informed Decisions about Breast Reconstruction (06-18-2014)

July 16, 2014 at 6:30pm EST CancerConnect live Web Chat with an Expert series presents:  “Making Informed Decisions about Breast Reconstruction.”  On July 16, 2014 at 6:30pm EST you will have the opportunity to engage with a breast cancer expert... Continue Reading

« Previous PageNext Page »